home / openregs / legislation

legislation: 109-s-2699

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
109-s-2699 109 s 2699 Elimination of Neglected Diseases Act of 2006 Commerce 2006-05-02 2006-05-02 Read twice and referred to the Committee on the Judiciary. Senate Sen. Brownback, Sam [R-KS] KS R B000953 1 Elimination of Neglected Diseases Act of 2006 - Provides for the extension and restoration of the patent term for a certified tropical disease product: (1) that is used to treat neglected or tropical diseases such as HIV, malaria, tuberculosis, or other infectious disease that disproportionately affect poor and marginalized populations; and (2) the patent for which claims an approved new molecular entity standard review drug or the process of making such a drug or the drug's active ingredient. Requires the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to: (1) designate as a new molecular entity standard review drug a drug that has a new molecular entity chemical type classification and standard review drug treatment potential classifications and is not a drug developed to treat serious or life-threatening diseases; and (2) maintain and annually update a classification list of serious and life-threatening diseases. Allows the Secretary, acting through the Commissioner, to remove the designation of a drug as a new molecular entity standard review drug. Requires the Director of the United States Patent and Trademark Office (USPTO) to study the effect of patent extension and restoration on the ability of pharmaceutical companies to develop and distribute tropical disease products for poor and marginalized populations. 2023-01-13T04:48:21Z  

Links from other tables

  • 3 rows from bill_id in legislation_actions
  • 18 rows from bill_id in legislation_subjects
  • 1 row from bill_id in legislation_cosponsors
  • 0 rows from bill_id in cbo_cost_estimates
Powered by Datasette · Queries took 0.396ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API